Phase 3 Clinical Trials

Browse Phase 3 clinical trials. AI-powered analysis of Phase 3 studies with plain English summaries and decoded eligibility.

A Phase 3b/4 Multi-center, Randomized, Open-label, Long-term Safety Study of Deucravacitinib in Comparison to Ustekinumab in Participants With Moderate-to-Severe Plaque Psoriasis

NCT07116967 · RECRUITING · Phase 3 · Bristol-Myers Squibb

Randomized Phase III Trial of Neoadjuvant Immunotherapy With Response-Adapted Treatment Versus Standard-of-Care Treatment for Resectable Stage III/IV Cutaneous Squamous Cell Carcinoma (C-PRE)

NCT06568172 · RECRUITING · Phase 3 · National Cancer Institute (NCI)

Other Phases